D. Ackermann

Grundare på

Presidio Medical, Inc.

44 år

10 relationer

Health Technology

Consumer Services

Commercial Services

Profil

Dr. D.
M.
Ackermann is an Advisor at Vensana Capital Management LLC, a Chief Executive Officer, CFO & Secretary at Osanni Bio, Inc. and a Director-Biotechnology at Stanford Byers Center for Biodesign.
He is on the Board of Directors at Presidio Medical, Inc. Dr. Ackermann was previously employed as a Chairman by Tarsus Pharmaceuticals, Inc., a Vice President-Neurostimulation by Allergan, Inc., a Chairman by Oyster Point Pharma, Inc., a President & Chief Executive Officer by Oculeve, Inc., and a Co-Founder by Tangible Science, Inc. He received his undergraduate degree from Vanderbilt University, a graduate degree from Case Western Reserve University and a doctorate degree from Case Western Reserve University.

Aktiva positioner av D. Ackermann

Företag	Position	Start
Presidio Medical, Inc. Presidio Medical, Inc. Medical SpecialtiesHealth Technology Develops neuromodulation platform to establish a class of therapeutic medical devices	Grundare	2017-01-01
Stanford Byers Center for Biodesign Stanford Byers Center for Biodesign Miscellaneous Commercial ServicesCommercial Services Engages in training of health technology innovators	Företagsledare/Principal	-
Vensana Capital Management LLC Vensana Capital Management LLC Investment ManagersFinance Vensana Capital invests in companies located across the globe, primarily in the United States. The firm focuses on companies operating in the field medical technology sector such as medical devices, life science tools & diagnostics, and data science & tech-enabled solutions. It provides financing for early and growth stage capital requirements with an investment size of USD 15 - 50 million.	Konsult / Rådgivare	2019-10-01

Alla aktiva positioner av D. Ackermann

Tidigare kända positioner av D. Ackermann

Företag	Position	Slut
TARSUS PHARMACEUTICALS, INC.	Grundare	2022-12-02
OYSR POIN	Grundare	2020-10-08
ALLERGAN, INC.	Företagsledare/Principal	2017-06-01
Oculeve, Inc. Oculeve, Inc. Medical SpecialtiesHealth Technology Develops devices for dry eye disease treatment	Verkställande Direktör	2015-08-11
Tangible Science, Inc. Tangible Science, Inc. Medical SpecialtiesHealth Technology Develops a novel polymer based coating technology for use in contact lenses to treat dry eye disease	Grundare	-

Se detaljerna i D. Ackermanns erfarenhet

D. Ackermanns utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i D. Ackermanns erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	10
Allergan, Inc. Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Oculeve, Inc. Oculeve, Inc. Medical SpecialtiesHealth Technology Develops devices for dry eye disease treatment	Health Technology
Vanderbilt University Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Case Western Reserve University Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Tangible Science, Inc. Tangible Science, Inc. Medical SpecialtiesHealth Technology Develops a novel polymer based coating technology for use in contact lenses to treat dry eye disease	Health Technology
Oyster Point Pharma, Inc. Oyster Point Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops and commercializes pharmaceutical therapies to treat ocular surface diseases	Commercial Services
Vensana Capital Management LLC Vensana Capital Management LLC Investment ManagersFinance Vensana Capital invests in companies located across the globe, primarily in the United States. The firm focuses on companies operating in the field medical technology sector such as medical devices, life science tools & diagnostics, and data science & tech-enabled solutions. It provides financing for early and growth stage capital requirements with an investment size of USD 15 - 50 million.	Finance
Tarsus Pharmaceuticals, Inc. Tarsus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapeutic drugs for blepharitis	Health Technology
Presidio Medical, Inc. Presidio Medical, Inc. Medical SpecialtiesHealth Technology Develops neuromodulation platform to establish a class of therapeutic medical devices	Health Technology
Stanford Byers Center for Biodesign Stanford Byers Center for Biodesign Miscellaneous Commercial ServicesCommercial Services Engages in training of health technology innovators	Commercial Services